Interestingly, the systemic treatment with anti-TGF-β1 antibody protected leptin-deficient (ob/ob) and diet-induced obese (DIO) mice against obesity and diabetes [14]. This evidence concerns the gene TGFB1 and obesity due to melanocortin 4 receptor deficiency.